BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28501429)

  • 1. Permanent prostate brachytherapy postimplant magnetic resonance imaging dosimetry using positive contrast magnetic resonance imaging markers.
    Martin GV; Pugh TJ; Mahmood U; Kudchadker RJ; Wang J; Bruno TL; Bathala T; Blanchard P; Frank SJ
    Brachytherapy; 2017; 16(4):761-769. PubMed ID: 28501429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postimplant Dosimetry of Permanent Prostate Brachytherapy: Comparison of MRI-Only and CT-MRI Fusion-Based Workflows.
    Nosrati R; Wronski M; Tseng CL; Chung H; Pejović-Milić A; Morton G; Stanisz GJ
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):206-215. PubMed ID: 31627178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of the CT/MRI fusion method as a learning tool for CT-based postimplant dosimetry in prostate brachytherapy.
    Tanaka O; Hayashi S; Sakurai K; Matsuo M; Nakano M; Maeda S; Hoshi H; Deguchi T
    Radiother Oncol; 2006 Dec; 81(3):303-8. PubMed ID: 17125859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of MRI-based and CT/MRI fusion-based postimplant dosimetric analysis of prostate brachytherapy.
    Tanaka O; Hayashi S; Matsuo M; Sakurai K; Nakano M; Maeda S; Kajita K; Deguchi T; Hoshi H
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):597-602. PubMed ID: 16966002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T2*-weighted image/T2-weighted image fusion in postimplant dosimetry of prostate brachytherapy.
    Katayama N; Takemoto M; Yoshio K; Katsui K; Uesugi T; Nasu Y; Matsushita T; Kaji M; Kumon H; Kanazawa S
    J Radiat Res; 2011; 52(5):680-4. PubMed ID: 21857148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of CT and MR-CT fusion for prostate post-implant dosimetry.
    Maletz KL; Ennis RD; Ostenson J; Pevsner A; Kagen A; Wernick I
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1912-7. PubMed ID: 21550183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deformable registration of x ray and MRI for postimplant dosimetry in low dose rate prostate brachytherapy.
    Hrinivich WT; Park S; Le Y; Song DY; Lee J
    Med Phys; 2019 Sep; 46(9):3961-3973. PubMed ID: 31215042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of MRI-based postimplant dosimetric assessment in prostate brachytherapy using contrast-enhanced T1-weighted images.
    Ohashi T; Momma T; Yamashita S; Nagatsuma K; Kanai K; Kitagawa K; Takahashi S; Hanada T; Yorozu A; Shigematsu N
    Brachytherapy; 2012; 11(6):468-75. PubMed ID: 22330102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI-CT fusion to assess postbrachytherapy prostate volume and the effects of prolonged edema on dosimetry following transperineal interstitial permanent prostate brachytherapy.
    Crook J; McLean M; Yeung I; Williams T; Lockwood G
    Brachytherapy; 2004; 3(2):55-60. PubMed ID: 15374536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward a deep learning-based magnetic resonance imaging only workflow for postimplant dosimetry in I-125 seed brachytherapy for prostate cancer.
    Grigo J; Karius A; Hanspach J; Mücke L; Laun FB; Huang Y; Strnad V; Fietkau R; Bert C; Putz F
    Brachytherapy; 2024; 23(1):96-105. PubMed ID: 38008648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate brachytherapy postimplant dosimetry: seed orientation and the impact of dosimetric anisotropy in stranded implants.
    Chng N; Spadinger I; Rasoda R; Morris WJ; Salcudean S
    Med Phys; 2012 Feb; 39(2):721-31. PubMed ID: 22320782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of combined x-ray radiography and magnetic resonance (XMR) imaging-versus computed tomography-based dosimetry for the evaluation of permanent prostate brachytherapy implants.
    Acher P; Rhode K; Morris S; Gaya A; Miquel M; Popert R; Tham I; Nichol J; McLeish K; Deehan C; Dasgupta P; Beaney R; Keevil SF
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1518-25. PubMed ID: 18513881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between pre- and postimplant dosimetry for iodine-125 seed implants for localized prostate cancer.
    Al-Qaisieh B; Witteveen T; Carey B; Henry A; Bottomley D; Smith J; Franks K; Bownes P
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):626-30. PubMed ID: 19540077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT- and MRI-based seed localization in postimplant evaluation after prostate brachytherapy.
    De Brabandere M; Al-Qaisieh B; De Wever L; Haustermans K; Kirisits C; Moerland MA; Oyen R; Rijnders A; Van den Heuvel F; Siebert FA
    Brachytherapy; 2013; 12(6):580-8. PubMed ID: 23876358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between postoperative TRUS-CT fusion with MRI-CT fusion for postimplant quality assurance in prostate LDR permanent seed brachytherapy.
    Tisseverasinghe S; Marbán M; Crook J; Petrik D; Araujo C
    Brachytherapy; 2021; 20(4):849-856. PubMed ID: 33867295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of intraoperative magnetic resonance imaging/ultrasound fusion optimization for low-dose-rate prostate brachytherapy.
    Abel S; Renz P; Gayou O; Tang J; Werts ED; Trombetta M
    J Contemp Brachytherapy; 2017 Aug; 9(4):309-315. PubMed ID: 28951749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of day 0 and day 14 dosimetry for permanent prostate implants using stranded seeds.
    McLaughlin P; Narayana V; Pan C; Berri S; Troyer S; Herman J; Evans V; Roberson P
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):144-50. PubMed ID: 16243441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of interobserver differences in postimplant dosimetry following prostate brachytherapy and the efficacy of CT/MRI fusion imaging.
    Aoki M; Yorozu A; Dokiya T
    Jpn J Radiol; 2009 Nov; 27(9):342-7. PubMed ID: 19943144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncertainty in magnetic resonance imaging-based prostate postimplant dosimetry: Results of a 10-person human observer study, and comparisons with automatic postimplant dosimetry.
    Sanders JW; Tang C; Kudchadker RJ; Venkatesan AM; Mok H; Hanania AN; Thames HD; Bruno TL; Starks C; Santiago E; Cunningham M; Frank SJ
    Brachytherapy; 2023; 22(6):822-832. PubMed ID: 37716820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sector analysis of dosimetry of prostate cancer patients treated with low-dose-rate brachytherapy.
    Nasser NJ; Wang Y; Borg J; Saibishkumar EP
    Brachytherapy; 2014; 13(4):369-74. PubMed ID: 24559795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.